Free Trial

Advisors Asset Management Inc. Has $3.09 Million Holdings in Sabra Healthcare REIT, Inc. $SBRA

Sabra Healthcare REIT logo with Finance background

Key Points

  • Advisors Asset Management Inc. increased its position in Sabra Healthcare REIT by 10.6%, owning approximately $3.09 million worth of the stock as of the latest SEC filing.
  • Multiple analysts have upgraded their target prices for Sabra Healthcare REIT, with current estimates ranging from $20.00 to $22.00, reflecting a generally positive outlook.
  • Sabra Healthcare REIT recently announced a quarterly dividend of $0.30, translating to an annualized yield of 6.3%.
  • Interested in Sabra Healthcare REIT? Here are five stocks we like better.

Advisors Asset Management Inc. raised its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 10.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 176,877 shares of the real estate investment trust's stock after purchasing an additional 16,886 shares during the quarter. Advisors Asset Management Inc. owned about 0.07% of Sabra Healthcare REIT worth $3,090,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new position in Sabra Healthcare REIT in the first quarter valued at about $298,000. New York State Teachers Retirement System increased its position in shares of Sabra Healthcare REIT by 12.1% during the first quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock worth $5,619,000 after acquiring an additional 34,591 shares during the last quarter. M&T Bank Corp increased its position in shares of Sabra Healthcare REIT by 2.1% during the first quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock worth $905,000 after acquiring an additional 1,059 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in shares of Sabra Healthcare REIT by 4.7% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock worth $331,000 after acquiring an additional 853 shares during the last quarter. Finally, Ethos Financial Group LLC purchased a new stake in shares of Sabra Healthcare REIT during the first quarter worth about $1,150,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SBRA has been the topic of a number of analyst reports. Truist Financial lifted their target price on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a research report on Tuesday, September 2nd. BMO Capital Markets lifted their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday, August 25th. JMP Securities lifted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Wells Fargo & Company lifted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. Finally, Scotiabank lifted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $20.71.

View Our Latest Stock Report on Sabra Healthcare REIT

Sabra Healthcare REIT Price Performance

SBRA traded down $0.08 during trading on Friday, reaching $19.05. The stock had a trading volume of 1,519,531 shares, compared to its average volume of 2,188,764. The firm has a market capitalization of $4.57 billion, a price-to-earnings ratio of 25.07, a price-to-earnings-growth ratio of 1.53 and a beta of 0.88. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The stock has a 50 day moving average of $18.68 and a two-hundred day moving average of $17.97.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 157.89%.

About Sabra Healthcare REIT

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Recommended Stories

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Healthcare REIT Right Now?

Before you consider Sabra Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.

While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.